Cardiac Surgery Market Size, Share, and Trends Analysis | United States | 2023-2029 | MedSuite | Includes: Tissue Heart Valve Market, TAVI/TAVR Market, and 22 more

  • Year: 2023
  • Scope: 10 Years
  • Region: United States
  • Pages: 543
  • Published Date: 08/30/2023
  • Type: MedSuite

Product Description

Overall, the U.S. cardiac surgery market was valued at $8.4 billion in 2022. This is expected to increase over the forecast period at a CAGR of 6.1% to reach $12.7 billion. Currently, the U.S. cardiac surgery market is dominated by Edwards Lifesciences, Abbott, and Medtronic.

Throughout this medical market research, we analyzed over 30 cardiac surgery companies across the U.S. and used our comprehensive methodology to understand the market sizes, unit sales, company market shares, and to create accurate forecasts. The full report suite on the U.S. market for cardiac surgery includes tissue heart valve, mechanical heart valve, annuloplasty repair device, transcatheter mitral valve repair device, transcatheter heart valve replacement (THVR), temporary pacing and pressure measurement catheter, cerebral embolic protection device, balloon valvuloplasty, on-pump coronary artery bypass (ONCAB) device, off-pump coronary artery bypass (OPCAB) device, autotransfusion device, endoscopic vessel harvesting device and anastomosis assist device markets, in addition to the transmyocardial revascularization, ventricular assist device (VAD), intra-aortic balloon pump (IABP), artificial heart replacement device, remote hemodynamic monitoring system, patent foramen ovale (PFO) closure device, patent ductus arteriosus (PDA) closure device, atrial septal and ventricular septal defect closure device, left atrial appendage (LAA) closure device, pre-shaped guidewire and extracorporeal membrane oxygenation (ECMO) markets..

DATA TYPES INCLUDED

  • Unit Sales, Average Selling Prices, Market Value & Growth Trends
  • Forecasts Until 2029, and Historical Data to 2019
  • Market Drivers & Limiters for Each Segment
  • Competitive Analysis with Market Shares for Each Segment
  • Recent Mergers & Acquisitions
  • COVID19 Impact
  • Disease Overviews and Demographic Information
  • Company Profiles, Product Portfolios and SWOT for Top Competitors

U.S. Cardiac Surgery Market Insights

u.s. cardiac surgery marketBy 2029, the U.S. cardiac surgery market is poised for remarkable expansion. This surge is primarily propelled by two key factors: the advancing age of the population and the escalating prevalence of cardiovascular ailments nationwide. Notably, a considerable patient base exists for a multitude of cardiac surgery devices applications.

For instance, within the United States, approximately 1.2 million individuals grapple with aortic valve calcification or other forms of impairment. Typically, these cases involve patients who harbor various concomitant health issues, rendering them unsuitable candidates for traditional invasive surgical interventions. A parallel scenario unfolds with children afflicted by congenital cardiac anomalies. Opting for percutaneous techniques in such cases presents the advantage of sparing them from recurrent invasive procedures as they progress through life. The immense potential within this populous demographic is primed to be a driving force behind the propulsion of this market’s growth.

The prevalence of atrial fibrillation (AF), a condition characterized by irregular heart rhythm, displays an observable correlation with advancing age. Clinical investigations underscore that the frequency of AF exhibits a twofold increase with every passing decade of adulthood. This trend is further amplified by the co-occurrence of various health conditions associated with AF, such as heart valve disorders, which also manifest more frequently in older age groups. Given that the segment of individuals aged 65 and above constitutes the swiftest-growing demographic within the United States, the incidence of AF is slated to continue its upward trajectory. Consequently, this surge in AF cases is set to be a catalyst for fostering expansion within the cardiac surgery market.

U.S. Cardiac Surgery Market Share Insight

u.s. cardiac surgery market share leaders

In 2022, the dominant player within the U.S. cardiac surgery market was Edwards Lifesciences. Their supremacy was primarily propelled by their remarkable foothold in the Transcatheter Heart Valve Replacement (THVR) category, contributing significantly to their overall market share. Edwards Lifesciences boasts an array of THVR options including SAPIEN 3 ULTRA®, SAPIEN 3®, and SAPIEN XT®. Beyond THVR, the company also maintains a robust influence in the segments of tissue heart valve solutions and annuloplasty offerings.

Securing the second position in the U.S. cardiac surgery market for 2022 was Abbott. This stature was fortified by Abbott’s strategic acquisition of St. Jude Medical, enabling them to incorporate a diverse structural heart portfolio. Notably, Abbott occupies a distinctive position as the exclusive player in the realm of remote hemodynamic monitoring, setting them apart. Furthermore, Abbott continues to maintain a principal role in the transcatheter mitral valve replacement sector.

Claiming the third spot in the U.S. cardiac surgery market hierarchy was Medtronic. Their ascendancy can be attributed to a prominent presence within the THVR sector, bolstered by their CoreValve Evolut R® Transcatheter Aortic Valve Replacement product.

Detailed Market Segmentation

Each of the markets below is available for purchase as a standalone report, a MedCore.

  • Tissue Heart Valve Market – MedCore – The market is further broken down into segments by:
    • Device Type: Stented, stentless and sutureless tissue heart valves.
    • Tissue Type: Xenograft heart valve market and the allograft heart valve market.
  • Mechanical Heart Valve Market – MedCore – The U.S. market for mechanical valves is segmented into mechanical valves without a conduit and mechanical valves with a conduit.
  • Annuloplasty Repair Device Market – MedCore – The U.S. market for annuloplasty repair devices is segmented into ring devices and band devices.
  • Transcatheter Mitral Valve Repair Device Market – MedCore – In-depth analysis of the Transcatheter Mitral Valve Repair Device market.
  • Transcatheter Heart Valve Replacement Market – MedCore – The U.S. market for THVR devices is segmented into devices used for aortic and pulmonary valve replacement.
  • Cerebral Embolic Protection Device Market – MedCore – In-depth analysis of the Cerebral Embolic Protection Device market.
  • Temporary Pacing and Pressure Measurement Catheter Market – MedCore – In-depth analysis of the Temporary Pacing and Pressure Measurement Catheter Market.
  • Balloon Valvuloplasty Market – MedCore – The BV market includes BV catheters used for aortic, mitral and pulmonary procedures.
  • On-Pump Coronary Artery Bypass Device Market – MedCore – The U.S. market for ONCAB devices consists of disposable devices and capital devices. Disposable devices included in the report include oxygenators, reservoirs, cardioplegia sets, filters, pump heads, bubble traps, hemoconcentrators, custom tubing kits and other markets. Capital devices include perfusion systems, also known as heart-lung machines.
  • Off-Pump Coronary Artery Bypass Device Market – MedCore – The analysis is further segmented by Stabilizer Device, Positioner, and OPCAB Accessories markets.
  • Autotransfusion Device Market – MedCore – The U.S. market for autotransfusion devices is composed of autotransfusion machines and disposables.
  • Endoscopic Vessel Harvesting Device Market – MedCore – The in-depth analysis of the Endoscopic Vessel Harvesting Device Market.
  • Anastomosis Assist Device (AAD) Market – MedCore – The U.S. market for AADs consists of proximal and distal devices.
  • Transmyocardial Revascularization Market – MedCore – The U.S. market for TMR devices is composed of disposable handpieces and laser consoles.
  • Ventricular Assist Device (VAD) Market – MedCore – For the purposes of this report, the U.S. market for VADs is divided into three main segments: pVADs, external VADs and implantable VADs. The pVAD market includes devices used in the left and right heart. External VADs are segmented by the length of support they provide due to the large difference in average selling price (ASP) between external VADs used for short- and long-term support. Implantable devices are used for BTR, BTT and DT.
  • Intra-Aortic Balloon Pump Market – MedCore – The IABP market includes both the console and catheter markets.
  • Artificial Heart Replacement Device Market – MedCore – The U.S. market for artificial heart replacement devices is currently entirely composed of temporary artificial heart devices.
  • Remote Hemodynamic Monitoring System Market – MedCore – The remote hemodynamic monitoring system market is a relatively new and rapidly growing market.
  • Patent Foramen Ovale Closure Device Market – MedCore – In-depth analysis of the Patent Foramen Ovale Closure Device market.
  • Patent Ductus Arteriosus Closure Device Market – MedCore – In-depth analysis of the Patent Ductus Arteriosus Closure Device market.
  • Atrial Septal & Ventricular Septal Defect Closure Device Market – MedCore – The U.S. market is powered primarily by sales of ASD closure devices. ASD closure devices are often used off-label to close PFO; however, this chapter will consider only ASD devices used to close ASDs, particularly secundum ASDs.
  • Left Atrial Appendage Closure Device Market – MedCore – The U.S. market for LAA closure devices is composed of endocardial and epicardial devices.
  • Preshaped Guidewire Market – MedCore – This report considers only guidewires indicated for use in TAVR.
  • Extracorporeal Membrane Oxygenation Market – MedCore – The ECMO market includes capital equipment and disposable products.

Research Scope Summary

Report AttributeDetails
RegionsUnited States
Base Year2022
Forecast2023-2029
Historical Data2019-2022
Quantitative CoverageMarket Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices.
Qualitative CoverageCOVID19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews.
Data SourcesPrimary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database.

 

FREE Sample Report

 

TABLE of CONTENTS
List of Figures
List of Charts
executive summary
U.S. Cardiac Surgery and Heart Valve Device Market Overview
Competitive Analysis
Market Trends
Market Developments
Procedures Included
Procedure Codes Investigated
Markets Included
Key Report Updates
Version History
research methodology
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems and Perform Secondary Research
Step 3: Preparation for Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast and Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review and Market Release
Step 9: Customer Feedback and Market Monitoring
impact of covid-19 on THE U.S. Cardiac Surgery and Heart Valve Device Market
2.1 Introduction
2.2 Analysis By Market Segment
2.2.1 Worst Case Scenario
2.2.2 Base Case Scenario
2.2.3 Best Case Scenario
Disease Overview
3.1 Basic Anatomy
3.2 Disease Treatments & Diagnostics
3.2.1 Coronary Artery Disease
3.2.2 Myocardial Infarction
3.2.3 Angina Pectoris
3.2.4 Heart Valve Disease
3.2.5 Congestive Heart Failure
3.2.6 Aortic Stenosis
3.2.7 Degenerative/Functional Mitral Regurgitation
3.3 Patient Demographics
3.3.1 General Statistics
3.3.2 Coronary Artery Disease
3.3.3 Myocardial Infarction
3.3.4 Angina Pectoris
3.3.5 Heart Valve Disease
3.3.6 Congestive Heart Failure
Product Assessment
4.1 Introduction
4.2 Product Portfolios
4.2.1 Tissue Heart Valve Device
4.2.2 Mechanical Heart Valve Device
4.2.3 Annuloplasty Repair Device
4.2.4 Transcatheter Mitral Valve Repair Device
4.2.5 Transcatheter Heart Valve Replacement Device
4.2.6 Cerebral Embolic Protection Device
4.2.7 Balloon Valvuloplasty Device
4.2.8 On-Pump Coronary Artery Bypass Device
4.2.9 Off-Pump Coronary Artery Bypass Device
4.2.10 Autotransfusion Device
4.2.11 Endoscopic Vessel Harvesting Device
4.2.12 Anastomosis Assist Device
4.2.13 Transmyocardial Revascularization Device
4.2.14 Ventricular Assist Device
4.2.15 Intra-Aortic Balloon Pump Device
4.2.16 Artificial Heart Replacement Device
4.2.17 Remote Hemodynamic Monitoring System Device
4.2.18 Patent Foramen Ovale Device
4.2.19 Patent Ductus Arteriosus Closure Device
4.2.20 Atrial & Ventricular Septal Defect Device
4.2.21 Left Atrial Appendage Closure Device
4.2.22 Preshaped Guidewires
4.2.23 Extracorporeal Membrane Oxygenation
4.2.24 Temporary Pacing and Pressure Measurement Catheter (for Transcatheter Heart Valve) Market
4.3 Regulatory Issues and Recalls
4.3.1 Tissue Heart Valve Market FDA Recalls
4.3.2 Mechanical Heart Valve Market FDA Recalls
4.3.3 Annuloplasty Repair Device Market FDA Recalls
4.3.4 Transcatheter Mitral Valve Repair Device Market FDA Recalls
4.3.5 Transcatheter Heart Valve Replacement Device Market FDA Recalls
4.3.6 On-Pump Coronary Artery Bypass Device Market FDA Recalls
4.3.7 Off-Pump Coronary Artery Bypass Device Market FDA Recalls
4.3.8 Autotransfusion Device Market FDA Recalls
4.3.9 Endoscopic Vessel Harvesting Device Market FDA Recalls
4.3.10 Anastomosis Assist Device Market FDA Recalls
4.3.11 Ventricular Assist Device Market FDA Recalls
4.3.12 Intra-Aortic Balloon Pump Market FDA Recalls
4.3.13 Artificial Heart Replacement Device Market FDA Recalls
4.3.14 Remote Hemodynamic Monitoring System Market FDA Recalls
4.3.15 Patent Foramen Ovale Device Market FDA Recalls
4.3.16 Atrial & Ventricular Septal Defect Device Market FDA Recalls
4.3.17 Preshaped Guidewires Market FDA Recalls
4.3.18 Extracorporeal Membrane Oxygenation FDA Recalls
4.3.19 Temporary Pacing and Pressure Measurement Catheter (for Transcatheter Heart Valve) Market FDA Recalls
4.4 Clinical Trials
4.4.1 Tissue Heart Valve Market Clinical Trials
4.4.2 Mechanical Heart Valve Market Clinical Trials
4.4.3 Annuloplasty Repair Device Market Clinical Trials
4.4.4 Transcatheter Mitral Valve Repair Device Market Clinical Trials
4.4.5 Transcatheter Heart Valve Replacement Device Market Clinical Trials
4.4.6 Cerebral Embolic Protection Device Market Clinical Trials
4.4.7 Balloon Valvuloplasty Market Clinical Trials
4.4.8 Endoscopic Vessel Harvesting Device Market Clinical Trials
4.4.9 Transmyocardial Revascularization Device Market Clinical Trials
4.4.10 Ventricular Assist Device Market Clinical Trials
4.4.11 Intra-Aortic Balloon Pump Market Clinical Trials
4.4.12 Artificial Heart Replacement Device Market Clinical Trials
4.4.13 Remote Hemodynamic Monitoring System Market Clinical Trials
4.4.14 Patent Foramen Ovale Device Market Clinical Trials
4.4.15 Patent Ductus Arteriosus Closure Device Market Clinical Trials
4.4.16 Left Atrial Appendage Closure Device Market Clinical Trials
4.4.17 Extracorporeal Membrane Oxygenation Clinical Trials
4.4.18 Temporary Pacing and Pressure Measurement Catheter (for Transcatheter Heart Valve) Market Clinical Trials
U.S. Cardiac Surgery and Heart Valve Device Market Overview
5.1 Introduction
5.2 Market Overview & Trend Analysis
5.3 Drivers and Limiters
5.3.1 Market Drivers
5.3.2 Market Limiters
5.4 Competitive Market Share Analysis
5.5 Mergers and Acquisitions
5.6 Company Profiles
5.6.1 Abbott
5.6.2 Abiomed
5.6.3 Artivion
5.6.4 AtriCure
5.6.5 B. Braun
5.6.6 Boston Scientific
5.6.7 Edwards Lifesciences
5.6.8 Getinge
5.6.9 LivaNova
5.6.10 Medtronic
5.6.11 Terumo
5.7 SWOT Analysis
5.7.1 Abbott
5.7.2 Abiomed
5.7.3 Artivion
5.7.4 AtriCure
5.7.5 B. Braun
5.7.6 Boston Scientific
5.7.7 Edwards Lifesciences
5.7.8 Getinge
5.7.9 LivaNova
5.7.10 Medtronic
5.7.11 Terumo
Procedure Numbers
6.1 Introduction
6.2 Cardiac Surgery and Heart Valve Procedures
6.3 Surgical Heart Valve Replacement Procedures
6.3.1 Tissue Heart Valve Procedures by Valve Type
6.3.2 Tissue Heart Valve Procedures by Tissue Type
6.3.3 Tissue Heart Valve Procedures by Device Type
6.3.4 Mechanical Heart Valve Procedures by Valve Type
6.3.5 Mechanical Heart Valve Procedures by Device Type
6.4 Annuloplasty Repair Procedures
6.4.1 Annuloplasty Repair Procedures by Valve Type
6.4.2 Annuloplasty Repair Procedures by Device Type
6.5 Transcatheter Mitral Valve Repair Procedures
6.6 Transcatheter Heart Valve Replacement Procedures
6.6.1 TAVR Procedures by Approach
6.6.2 TAVR Procedures by Patient Risk Class
6.6.3 TAVR Procedures by Embolic Protection
6.6.4 TAVR Procedures by Location
6.6.5 TAVR Procedures by Valve Type
6.6.6 TPVR Procedures
6.7 Balloon Valvuloplasty Procedures
6.8 Coronary Artery Bypass Grafting Procedures
6.8.1 CABG Procedures by Bypass Type
6.8.2 CABG Vessel Harvesting Procedures by Type
6.8.3 CABG Procedures by Suture Type
6.8.4 CABG Procedures by Approach
6.9 Transmyocardial Revascularization Procedures
6.10 Ventricular Assist Device Procedures
6.10.1 Percutaneous VAD Procedures
6.10.1.1 Percutaneous VAD Procedures by Heart Side
6.10.1.2 Percutaneous VAD Procedures by Indication
6.10.2 Implantable VAD Procedures
6.10.2.1 Implantable VAD Procedures by Indication
6.10.2.2 Implantable VAD Procedures by Type
6.10.3 External VAD Procedures
6.11 Intra-Aortic Balloon Counterpulsation Procedures
6.11.1 IABP Procedures by Setting
6.11.2 IABP Procedures by Device Type
6.12 Heart Transplant Procedures
6.13 Remote Hemodynamic Monitoring System Procedures
6.14 Patent Foramen Ovale Closure Procedures
6.15 Patent Ductus Arteriosus Device Procedures
6.16 Septal Defect Closure Procedures
6.16.1 Atrial Septal Defect Closure Procedures
6.16.2 Ventricular Septal Defect Closure Procedures
6.17 Left Atrial Appendage Closure Procedures
6.17.1 Epicardial Device Procedures
6.17.1.1 Epicardial Clip Procedures by Type
6.18 Extracorporeal Membrane Oxygenation Procedures
6.18.1 Extracorporeal Membrane Oxygenation Procedures by Modality
6.18.2 Extracorporeal Membrane Oxygenation Procedures by Application
6.18.2.1 Respiratory Extracorporeal Membrane Oxygenation Procedures by Age Group
6.18.2.2 Cardiac Extracorporeal Membrane Oxygenation Procedures by Age Group
6.18.2.3 Extracorporeal Cardiopulmonary Resuscitation (eCPR) ECMO Procedures by Age Group
Tissue heart valve Market
7.1 Introduction
7.2 Market Overview
7.3 Market Analysis and Forecast
7.3.1 Total Tissue Heart Valve Market
7.3.2 Stented Market
7.3.3 Stentless Market
7.3.4 Sutureless/Rapid Deployment Market
7.3.5 By Tissue Type
7.4 Drivers and Limiters
7.4.1 Market Drivers
7.4.2 Market Limiters
7.5 Competitive Market Share Analysis
Mechanical heart valve Market
8.1 Introduction
8.2 Market Overview
8.3 Market Analysis and Forecast
8.3.1 Total Mechanical Heart Valve Market
8.3.2 Without Conduit Market
8.3.3 With Conduit Market
8.4 Drivers and Limiters
8.4.1 Market Drivers
8.4.2 Market Limiters
8.5 Competitive Market Share Analysis
Annuloplasty Repair Device Market
9.1 Introduction
9.2 Market Overview
9.3 Market Analysis and Forecast
9.3.1 Total Annuloplasty Repair Device Market
9.3.2 Ring Market
9.3.3 Band Market
9.4 Drivers and Limiters
9.4.1 Market Drivers
9.4.2 Market Limiters
9.5 Competitive Market Share Analysis
Transcatheter Mitral Valve Repair Market
10.1 Introduction
10.2 Market Analysis and Forecast
10.3 Drivers and Limiters
10.3.1 Market Drivers
10.3.2 Market Limiters
10.4 Competitive Market Share Analysis
Transcatheter heart valve replacement Market
11.1 Introduction
11.2 Market Overview
11.3 Market Analysis and Forecast
11.3.1 Total Transcatheter Heart Valve Replacement Market
11.3.2 Transcatheter Aortic Valve Replacement Market
11.3.3 Transcatheter Pulmonary Valve Replacement Market
11.4 Drivers and Limiters
11.4.1 Market Drivers
11.4.2 Market Limiters
11.5 Competitive Market Share Analysis
Temporary Pacing and Pressure Measurement Catheter Market
12.1 Introduction
12.2 Market Analysis and Forecast
12.3 Drivers and Limiters
12.3.1 Market Drivers
12.3.2 Market Limiters
12.4 Competitive Market Share Analysis
Cerebral Embolic Protection Device Market
13.1 Introduction
13.2 Market Analysis and Forecast
13.3 Drivers and Limiters
13.3.1 Market Drivers
13.3.2 Market Limiters
13.4 Competitive Market Share Analysis
BAlloon valvuloplasty Market
14.1 Introduction
14.2 Market Overview
14.3 Market Analysis and Forecast
14.3.1 Total Balloon Valvuloplasty Market
14.3.2 Aortic Market
14.3.3 Mitral Market
14.3.4 Pulmonary Market
14.3.5 Hybrid Market
14.4 Drivers and Limiters
14.4.1 Market Drivers
14.4.2 Market Limiters
14.5 Competitive Market Share Analysis
On-Pump Coronary Artery Bypass Device Market
15.1 Introduction
15.2 Market Overview
15.3 Market Analysis and Forecast
15.3.1 On-Pump Coronary Artery Bypass Disposables Market
15.3.1.1 Oxygenator Market
15.3.1.2 Reservoir Market
15.3.1.3 Cardioplegia Set Market
15.3.1.4 Filter Market
15.3.1.5 Pump Head Market
15.3.1.6 Bubble Trap Market
15.3.1.7 Hemoconcentrator Market
15.3.1.8 Custom Tubing Kit Market
15.3.1.9 Other Market
15.3.2 Perfusion System Market
15.4 Drivers and Limiters
15.4.1 Market Drivers
15.4.2 Market Limiters
15.5 Competitive Market Share Analysis
Off-Pump Coronary Artery Bypass Device Market
16.1 Introduction
16.2 Market Overview
16.3 Market Analysis and Forecast
16.3.1 Total Off-Pump Coronary Artery Bypass Market
16.3.2 Stabilizer Device Market
16.3.3 Positioner Market
16.3.4 Accessory Market
16.3.4.1 Blower/Mister Market
16.3.4.2 Intracoronary Shunt Market
16.4 Drivers and Limiters
16.4.1 Market Drivers
16.4.2 Market Limiters
16.5 Competitive Market Share Analysis
Autotransfusion Device Market
17.1 Introduction
17.2 Market Overview
17.3 Market Analysis and Forecast
17.3.1 Total Autotransfusion Device Market
17.3.2 Autotransfusion Machine Market
17.3.2.1 Autotransfusion Machine Installed Base by Agreement
17.3.3 Autotransfusion Disposables Market
17.4 Drivers and Limiters
17.4.1 Market Drivers
17.4.2 Market Limiters
17.5 Competitive Market Share Analysis
Endoscopic Vessel Harvesting Device Market
18.1 Introduction
18.2 Market Analysis and Forecast
18.3 Drivers and Limiters
18.3.1 Market Drivers
18.3.2 Market Limiters
18.4 Competitive Market Share Analysis
Anastomosis Assist Device Market
19.1 Introduction
19.2 Market Overview
19.3 Market Analysis and Forecast
19.3.1 Total Anastomosis Assist Device Market
19.3.2 Proximal Anastomosis Assist Device Market
19.3.3 Distal Anastomosis Assist Device Market
19.4 Drivers and Limiters
19.4.1 Market Drivers
19.4.2 Market Limiters
19.5 Competitive Market Share Analysis
Transmyocardial Revascularization Market
20.1 Introduction
20.2 Market Overview
20.3 Market Analysis and Forecast
20.3.1 Single-Use Fiber-Optic Handpiece Market
20.3.2 Transmyocardial Revascularization Laser Console Market
20.4 Drivers and Limiters
20.4.1 Market Drivers
20.4.2 Market Limiters
20.5 Competitive Market Share Analysis
Ventricular Assist Device Market
21.1 Introduction
21.2 Market Overview
21.3 Market Analysis and Forecast
21.3.1 Total Ventricular Assist Device Market
21.3.2 Percutaneous VAD Market
21.3.2.1 Left Heart Percutaneous VAD Market
21.3.2.2 Right Heart Percutaneous VAD Market
21.3.3 External VAD Market
21.3.3.1 Short-Term External VAD Market
21.3.3.2 Long-Term External VAD Market
21.3.4 Implantable VAD Market
21.3.4.1 Implantable VAD Market Unit Analysis
21.4 Drivers and Limiters
21.4.1 Market Drivers
21.4.2 Market Limiters
21.5 Competitive Market Share Analysis
Intra-Aortic Balloon Pump Market
22.1 Introduction
22.2 Market Overview
22.3 Market Analysis and Forecast
22.3.1 Total Intra-Aortic Balloon Pump Market
22.3.2 Intra-Aortic Balloon Pump Catheter Market
22.3.2.1 Conventional Intra-Aortic Balloon Pump Catheter Market
22.3.2.2 Fiber-Optic Intra-Aortic Balloon Pump Catheter Market
22.3.3 Intra-Aortic Balloon Pump Console Market
22.4 Drivers and Limiters
22.4.1 Market Drivers
22.4.2 Market Limiters
22.5 Competitive Market Share Analysis
Artificial Heart Replacement Device Market
23.1 Introduction
23.2 Market Analysis and Forecast
23.3 Drivers and Limiters
23.3.1 Market Drivers
23.3.2 Market Limiters
23.4 Competitive Market Share Analysis
Remote Hemodynamic Monitoring System Market
24.1 Introduction
24.2 Market Analysis and Forecast
24.3 Drivers and Limiters
24.3.1 Market Drivers
24.3.2 Market Limiters
24.4 Competitive Market Share Analysis
Patent Foramen Ovale Closure Device Market
25.1 Introduction
25.2 Market Analysis and Forecast
25.3 Drivers and Limiters
25.3.1 Market Drivers
25.3.2 Market Limiters
25.4 Competitive Market Share Analysis
Patent Ductus Arteriosus Closure Device Market
26.1 Introduction
26.2 Market Analysis and Forecast
26.3 Drivers and Limiters
26.3.1 Market Drivers
26.3.2 Market Limiters
26.4 Competitive Market Share Analysis
Atrial Septal & Ventricular Septal Defect Closure Device Market
27.1 Introduction
27.2 Market Overview
27.3 Market Analysis and Forecast
27.3.1 Total Atrial Septal & Ventricular Septal Defect Closure Device Market
27.3.2 Atrial Septal Defect Closure Device Market
27.3.3 Ventricular Septal Defect Closure Device Market
27.4 Drivers and Limiters
27.4.1 Market Drivers
27.4.2 Market Limiters
27.5 Competitive Market Share Analysis
Left Atrial Appendage Closure Device Market
28.1 Introduction
28.2 Market Overview
28.3 Market Analysis and Forecast
28.3.1 Total Left Atrial Appendage Closure Device Market
28.3.2 Epicardial Device Market
28.3.2.1 Epicardial Clip Device Market
28.3.2.1.1 Open Epicardial Clip Device Market
28.3.2.1.2 MIS Epicardial Clip Device Market
28.3.2.2 Epicardial Suture Device Market
28.3.3 Endocardial Device Market
28.4 Drivers and Limiters
28.4.1 Market Drivers
28.4.2 Market Limiters
28.5 Competitive Market Share Analysis
PReshaped Guidewire Market
29.1 Introduction
29.2 Market Analysis and Forecast
29.2.1 Total Preshaped Guidewire Market
29.3 Drivers and Limiters
Market Drivers
29.3.1 Market Limiters
29.4 Competitive Market Share Analysis
Extracorporeal Membrane Oxygenation Market
30.1 Introduction
30.2 Market Overview
30.3 Market Analysis and Forecast
30.3.1 Extracorporeal Membrane Oxygenation Machine Market
30.3.2 Extracorporeal Membrane Oxygenation Disposables Market
30.3.2.1 Venovenous Market
30.3.2.2 Venoarterial Market
30.3.2.3 Arteriovenous Market
30.4 Drivers and Limiters
30.4.1 Market Drivers
30.4.2 Market Limiters
30.5 Competitive Market Share Analysis
Abbreviations
The Cardiac Surgery Market Report Suite| United States | 2023-2029 | MedSuite includes analysis on the following companies currently active in this market:
·         Abbott·         Laser Engineering
·         Abiomed·         LifeNet Health
·         Artivion·         Lifetech
·         AtriCure·         LivaNova
·         B. Braun·         Medtronic
·         Becton Dickinson·         Merit Medical Systems
·         Berlin Heart·         Minntech
·         Biostable·         OpSens
·         Boston Scientific·         Peters Surgical
·         Cardia·         PFM Medical
·         Chase Medical·         Saphena Medical
·         Cook Medical·         SentreHEART
·         Corcym·         Spectrum Medical
·         Edwards Lifesciences·         SynCardia
·         Fresenius·         Teleflex
·         Genesee Biomedical·         Terumo
·         Getinge·         Toray
·         Gore·         Venus Medtech
·         Haemonetics
Chart 1‑1: Cardiac Surgery Market by Segment, U.S., 2022 – 2029
Chart 1‑2: Cardiac Surgery Market Overview, U.S., 2022 & 2029
Chart 2‑1: Multi-Scenario Cardiac Surgery Market Forecast, U.S., 2019 – 2029 (US$M)
Chart 5‑1: Cardiac Surgery Market by Segment, U.S., 2019 – 2029
Chart 5‑2: Leading Competitors, Cardiac Surgery Market, U.S., 2022
Chart 6‑1: Cardiac Surgery Procedures by Segment, U.S., 2019 – 2029
Chart 7‑1: Tissue Heart Valve Market by Segment, U.S., 2019 – 2029
Chart 7‑2: Leading Competitors, Tissue Heart Valve Market, U.S., 2022
Chart 8‑1: Total Mechanical Heart Valve Market by Segment, U.S., 2019 – 2029
Chart 8‑2: Leading Competitors, Mechanical Heart Valve Market, U.S., 2022
Chart 9‑1: Annuloplasty Repair Device Market by Segment, U.S., 2019 – 2029
Chart 9‑2: Leading Competitors, Annuloplasty Repair Device Market, U.S., 2022
Chart 10‑1: Transcatheter Mitral Valve Repair Market, U.S., 2019 – 2029
Chart 10‑2: Leading Competitors, Transcatheter Mitral Valve Repair Market, U.S., 2022
Chart 11‑1: Transcatheter Heart Valve Replacement Market by Segment, U.S., 2019 – 2029
Chart 11‑2: Leading Competitors, Transcatheter Heart Valve Replacement Market, U.S., 2022
Chart 12‑1: Temporary Pacing and Pressure Measurement Catheter Market, U.S., 2019 – 2029
Chart 12‑2: Leading Competitors, Temporary Pacing and Pressure Measurement Catheter Market, U.S., 2022
Chart 13‑1: Cerebral Embolic Protection Device Market, U.S., 2019 – 2029
Chart 14‑1: Balloon Valvuloplasty Market by Segment, U.S., 2019 – 2029
Chart 14‑2: Leading Competitors, Balloon Valvuloplasty Market, U.S., 2022
Chart 15‑1: On-Pump Coronary Artery Bypass Device Market by Segment, U.S., 2019 – 2029
Chart 15‑2: Leading Competitors, On-Pump Coronary Artery Bypass Device Market, U.S., 2022
Chart 16‑1: Off-Pump Coronary Artery Bypass Device Market by Segment, U.S., 2019 – 2029
Chart 16‑2: Leading Competitors, Off-Pump Coronary Artery Bypass Device Market, U.S., 2022
Chart 17‑1: Autotransfusion Device Market by Segment, U.S., 2019 – 2029
Chart 17‑2: Leading Competitors, Autotransfusion Device Market, U.S., 2022
Chart 18‑1: Endoscopic Vessel Harvesting Device Market, U.S., 2019 – 2029
Chart 18‑2: Leading Competitors, Endoscopic Vessel Harvesting Device Market, U.S., 2022
Chart 19‑1: Anastomosis Assist Device Market by Segment, U.S., 2019 – 2029
Chart 19‑2: Leading Competitors, Anastomosis Assist Device Market, U.S., 2022
Chart 20‑1: Transmyocardial Revascularization Market by Segment, U.S., 2019 – 2029
Chart 20‑2: Leading Competitors, Transmyocardial Revascularization Market, U.S., 2022
Chart 21‑1: Ventricular Assist Device Market by Segment, U.S., 2019 – 2029
Chart 21‑2: Leading Competitors, Ventricular Assist Device Market, U.S., 2022
Chart 22‑1: Intra-Aortic Balloon Pump Market by Segment, U.S., 2019 – 2029
Chart 22‑2: Leading Competitors, Intra-Aortic Balloon Pump Market, U.S., 2022
Chart 23‑1: Artificial Heart Replacement Device Market, U.S., 2019 – 2029
Chart 24‑1: Remote Hemodynamic Monitoring System Market, U.S., 2019 – 2029
Chart 25‑1: Patent Foramen Ovale Closure Device Market, U.S., 2019 – 2029
Chart 25‑2: Leading Competitors, Patent Foramen Ovale Closure Device Market, U.S., 2022
Chart 26‑1: Patent Ductus Arteriosus Closure Device Market, U.S., 2019 – 2029
Chart 26‑2: Leading Competitors, Patent Ductus Arteriosus Closure Device Market, U.S., 2022
Chart 27‑1: Atrial Septal & Ventricular Septal Defect Closure Device Market by Segment, U.S., 2019 – 2029
Chart 27‑2: Leading Competitors, Atrial Septal & Ventricular Septal Defect Closure Device Market, U.S., 2022
Chart 28‑1: Left Atrial Appendage Closure Device Market by Segment, U.S., 2019 – 2029
Chart 28‑2: Leading Competitors, Left Atrial Appendage Closure Device Market, U.S., 2022
Chart 29‑1: Preshaped Guidewire Market, U.S., 2019 – 2029
Chart 29‑2: Leading Competitors, Preshaped Guidewire Market, U.S., 2022
Chart 30‑1: Extracorporeal Membrane Oxygenation Market by Segment, U.S., 2019 – 2029
Chart 30‑2: Leading Competitors, ECMO Market, U.S., 2022
Figure 1‑1: Cardiac Surgery Market Share Ranking by Segment, U.S., 2022 (1 of 5)
Figure 1‑2: Cardiac Surgery Market Share Ranking by Segment, U.S., 2022 (2 of 5)
Figure 1‑3: Cardiac Surgery Market Share Ranking by Segment, U.S., 2022 (3 of 5)
Figure 1‑4: Cardiac Surgery Market Share Ranking by Segment, U.S., 2022 (4 of 5)
Figure 1‑5: Cardiac Surgery Market Share Ranking by Segment, U.S., 2022 (5 of 5)
Figure 1‑6: Companies Researched in This Report
Figure 1‑7: Factors Impacting the Cardiac Surgery Market by Segment, U.S. (1 of 5)
Figure 1‑8: Factors Impacting the Cardiac Surgery Market by Segment, U.S. (2 of 5)
Figure 1‑9: Factors Impacting the Cardiac Surgery Market by Segment, U.S. (3 of 5)
Figure 1‑10: Factors Impacting the Cardiac Surgery Market by Segment, U.S. (4 of 5)
Figure 1‑11: Factors Impacting the Cardiac Surgery Market by Segment, U.S. (5 of 5)
Figure 1‑12: Recent Events in the Cardiac Surgery Market, U.S., 2019 – 2023
Figure 1‑13: Cardiac Surgery Procedures Covered (1 of 5)
Figure 1‑14: Cardiac Surgery Procedures Covered (2 of 5)
Figure 1‑15: Cardiac Surgery Procedures Covered (3 of 5)
Figure 1‑16: Cardiac Surgery Procedures Covered (4 of 5)
Figure 1‑17: Cardiac Surgery Procedures Covered (5 of 5)
Figure 1‑18: Procedure Codes Investigated
Figure 1‑19: Cardiac Surgery Markets Covered (1 of 3)
Figure 1‑20: Cardiac Surgery Markets Covered (2 of 3)
Figure 1‑21: Cardiac Surgery Markets Covered (3 of 3)
Figure 1‑22: Key Report Updates
Figure 1‑23: Version History
Figure 2‑1: Cardiac Surgery Market by Segment, Worst Case Scenario, U.S., 2019 – 2029 (US$M) (1 of 3)
Figure 2‑2: Cardiac Surgery Market by Segment, Worst Case Scenario, U.S., 2019 – 2029 (US$M) (2 of 3)
Figure 2‑3: Cardiac Surgery Market by Segment, Worst Case Scenario, U.S., 2019 – 2029 (US$M) (3 of 3)
Figure 2‑4: Cardiac Surgery Market by Segment, Base Case Scenario, U.S., 2019 – 2029 (US$M) (1 of 3)
Figure 2‑5: Cardiac Surgery Market by Segment, Base Case Scenario, U.S., 2019 – 2029 (US$M) (2 of 3)
Figure 2‑6: Cardiac Surgery Market by Segment, Base Case Scenario, U.S., 2019 – 2029 (US$M) (3 of 3)
Figure 2‑7: Cardiac Surgery Market by Segment, Best Case Scenario, U.S., 2019 – 2029 (US$M) (1 of 3)
Figure 2‑8: Cardiac Surgery Market by Segment, Best Case Scenario, U.S., 2019 – 2029 (US$M) (2 of 3)
Figure 2‑9: Cardiac Surgery Market by Segment, Best Case Scenario, U.S., 2019 – 2029 (US$M) (3 of 3)
Figure 4‑1: Tissue Heart Valve Devices by Company
Figure 4‑2: Mechanical Heart Valve Devices by Company
Figure 4‑3: Annuloplasty Repair Devices by Company
Figure 4‑4: Transcatheter Mitral Valve Repair Devices by Company
Figure 4‑5: Transcatheter Heart Valve Replacement Devices by Company
Figure 4‑6: Cerebral Embolic Protection Devices by Company
Figure 4‑7: Balloon Valvuloplasty Devices by Company
Figure 4‑8: On-Pump Coronary Artery Bypass Devices by Company (1 of 2)
Figure 4‑9: On-Pump Coronary Artery Bypass Devices by Company (2 of 2)
Figure 4‑10: Off-Pump Coronary Artery Bypass Devices by Company (1 of 2)
Figure 4‑11: Off-Pump Coronary Artery Bypass Devices by Company (2 of 2)
Figure 4‑12: Autotransfusion Devices by Company
Figure 4‑13: Endoscopic Vessel Harvesting Devices by Company
Figure 4‑14: Anastomosis Assist Devices by Company
Figure 4‑15: Transmyocardial Revascularization Devices by Company
Figure 4‑16: Ventricular Assist Devices by Company
Figure 4‑17: Intra-Aortic Balloon Pump Devices by Company
Figure 4‑18: Artificial Heart Replacement Devices by Company
Figure 4‑19: Remote Hemodynamic Monitoring System Devices by Company
Figure 4‑20: Patent Foramen Ovale Devices by Company
Figure 4‑21: Patent Ductus Arteriosus Closure Devices by Company
Figure 4‑22: Atrial & Ventricular Septal Defect Devices by Company
Figure 4‑23: Left Atrial Appendage Closure Devices by Company
Figure 4‑24: Preshaped Guidewires by Company
Figure 4‑25: Extracorporeal Membrane Oxygenation by Company (1 of 2)
Figure 4‑26: ECMO by Company (2 of 2)
Figure 4‑27: Temporary Pacing and Pressure Measurement Catheter by Company
Figure 4‑28: Class 2 Device Recall CryoValve SG Pulmonary Human Heart Valve
Figure 4‑29: Class 2 Device Recall PERCEVAL SUTURELESS HEART VALVE
Figure 4‑30: Class 2 Device Recall Hancock II T510 Bioprosthesis
Figure 4‑31: Class 2 Device Recall Mosaic 310 Bioprosthesis
Figure 4‑32: Class 2 Device Recall Cryovalve(R) SG Pulmonary Human Heart Valve
Figure 4‑33: Class 2 Device Recall, CryoLife
Figure 4‑34: Class 2 Device Recall Medtronic Open Pivot Aortic Valve Graft
Figure 4‑35: Class 2 Device Recall OnX Aortic Heart Valve
Figure 4‑36: Class 1 Device Recall, CryoLife
Figure 4‑37: Class 2 Device Recall Medtronic Simulus 850 Semi Rigid Ring/Band Accessory Kit
Figure 4‑38: Class 2 Device Recall Medtronic Simulus 750 Flexible Ring/Band Accessory Kit
Figure 4‑39: Class 2 Device Recall MitraClip" and TriClip" Delivery System(s)
Figure 4‑40: Class 2 Device Recall Abbott MitraClip XTR Clip Delivery System
Figure 4‑41: Class 2 Device Recall, Abbott
Figure 4‑42: Class 1 Device Recall Harmony Delivery Catheter System
Figure 4‑43: Class 1 Device Recall Lotus Edge Valve System
Figure 4‑44: Class 1 Device Recall Edwards Sapien 3 Ultra Delivery System
Figure 4‑45: Class 2 Device Recall Edwards SAPIEN 3 Transcatheter Heart Valve (THV)
Figure 4‑46: Class 2 Device Recall Quadroxi Pediatric
Figure 4‑47: Class 2 Device Recall QUADROXi Small Adult
Figure 4‑48: Class 2 Device Recall QUADROX i Neonatal
Figure 4‑49: Class 2 Device Recall QUADROXi Small Adult, BIOLINE Coated
Figure 4‑50: Class 2 Device Recall QUADROX iR
Figure 4‑51: Class 2 Device Recall Quadroxi Adult
Figure 4‑52: Class 2 Device Recall QUADROXi Small
Figure 4‑53: Class 2 Device Recall CAPIOX NX19
Figure 4‑54: Class 2 Device Recall CAPIOX RX15
Figure 4‑55: Class 2 Device Recall CAPIOX FX25
Figure 4‑56: Class 2 Device Recall Affinity Fusion Oxygenator
Figure 4‑57: Class 1 Device Recall LifeSPARC Controller
Figure 4‑58: Class 1 Device Recall Affinity Pixie Oxygenator and Cardiotomy/Venous Reservoir with Balance Biosurface
Figure 4‑59: Class 2 Device Recall Capiox FX25 Advance Oxygenator
Figure 4‑60: Class 3 Device Recall ROTAFLOW Centrifugal Pump System
Figure 4‑61: Class 2 Device Recall ROTAFLOW Centrifugal Pump System
Figure 4‑62: Class 2 Device Recall Maquet/Getinge
Figure 4‑63: Class 3 Device Recall Smart Perfusion Pack
Figure 4‑64: Class 2 Device Recall Terumo Capiox NX19 Oxygenator
Figure 4‑65: Class 2 Device Recall
Figure 4‑66: Class 2 Device Recall ACROBAT V
Figure 4‑67: Class 2 Device Recall ACROBAT SUV
Figure 4‑68: Class 2 Device Recall ACROBATi
Figure 4‑69: Class 2 Device Recall CS Elite Fastpack
Figure 4‑70: Class 2 Device Recall CS Elite
Figure 4‑71: Class 2 Device Recall CS5/5 Fastpacks
Figure 4‑72: Class 2 Device Recall Cell Saver
Figure 4‑73: Class 2 Device Recall High Speed Cell Saver
Figure 4‑74: Class 2 Device Recall CSE Set
Figure 4‑75: Class 2 Device Recall CATSmart Autotransfusion
Figure 4‑76: Class 2 Device Recall CATSmart Vacuum Pump
Figure 4‑77: Class 2 Device Recall VASOVIEW HEMOPRO
Figure 4‑78: Class 2 Device Recall VASOVIEW HEMOPRO 2
Figure 4‑79: Class 2 Device Recall Cardica CPort xA PLUS Anastomosis System
Figure 4‑80: Class 2 Device Recall HeartWare" Ventricular Assist Device (HVAD") System
Figure 4‑81: Class 1 Device Recall Impella RP Flex with SmartAssist
Figure 4‑82: Class 1 Device Recall Impella LD
Figure 4‑83: Class 1 Device Recall Impella CP with SmartAssist
Figure 4‑84: Class 1 Device Recall Impella 5.0
Figure 4‑85: Class 1 Device Recall Impella 2.5
Figure 4‑86: Class 1 Device Recall Impella CP
Figure 4‑87: Class 2 Device Recall HeartWare
Figure 4‑88: Class 1 Device Recall Heartware HVAD
Figure 4‑89: Class 1 Device Recall HeartWare HVAD Pump Implant Kit
Figure 4‑90: Class 2 Device Recall HeartWare Ventricular Assist Device (HVAD) System
Figure 4‑91: Class 2 Device Recall HeartWare HVAD System
Figure 4‑92: Class 2 Device Recall HeartMate Touch Communication System
Figure 4‑93: Class 2 Device Recall TandemHeart Pump
Figure 4‑94: Class 1 Device Recall HVAD Pump Implant Kit
Figure 4‑95: Class 1 Device Recall HVAD Pump Outflow Graft
Figure 4‑96: Class 2 Device Recall HeartMate 3 Left Ventricular Assist System
Figure 4‑97: Class 2 Device Recall HeartMate Left Ventricular Assist System
Figure 4‑98: Class 2 Device Recall HeartMate Outflow Graft
Figure 4‑99: Class 1 Device Recall Cardiosave Rescue IntraAortic Balloon Pump (IABP)
Figure 4‑100: Class 1 Device Recall Cardiosave Rescue IntraAortic Balloon Pump (IABP)
Figure 4‑101: Class 1 Device Recall Cardiosave Hybrid IntraAortic Balloon Pump (IABP)
Figure 4‑102: Class 1 Device Recall Cardiosave Hybrid IntraAortic Balloon Pump (IABP)
Figure 4‑103: Class 2 Device Recall Cardiosave Rescue
Figure 4‑104: Class 2 Device Recall Safety Disk
Figure 4‑105: Class 2 Device Recall Cardiosave Rescue
Figure 4‑106: Class 2 Device Recall Cardiosave Hybrid
Figure 4‑107: Class 1 Device Recall Cardiosave Hybrid IntraAortic Balloon Pump (IABP)
Figure 4‑108: Class 1 Device Recall Arrow AutoCAT2
Figure 4‑109: Class 1 Device Recall Arrow AC3 Optimus
Figure 4‑110: Class 1 Device Recall AutoCAT IABP Series
Figure 4‑111: Class 1 Device Recall Arrow AutoCAT2
Figure 4‑112: Class 1 Device Recall AC3 Series IABP System
Figure 4‑113: Class 2 Device Recall SynCardia temporary Total Artificial Heart System
Figure 4‑114: Class 2 Device Recall CardioMEMS
Figure 4‑115: Class 2 Device Recall CardioMEMSTM HF System Hospital Electronics System (HES)
Figure 4‑116: Class 2 Device Recall CardioMEMSTM HF System Patient Electronics System (PES)
Figure 4‑117: Class 2 Device Recall Gore Cardioform Septal Occluder
Figure 4‑118: Class 2 Device Recall GORE CARDIOFORM SEPTAL OCCLUDER
Figure 4‑119: Class 2 Device Recall GORE CARDIOFORM ASD Occluder
Figure 4‑120: Class 2 Device Recall Lunderquist Ring Torque Wire Guide
Figure 4‑121: Class 1 Device Recall Medtronic Confida Expandable Sheath
Figure 4‑122: Class 2 Device Recall HLS Set Advanced
Figure 4‑123: Class 2 Device Recall HLS Set Advanced
Figure 4‑124: Class 3 Device Recall Cardiac Assist
Figure 4‑125: Class 2 Device Recall TandemHeart Pump
Figure 4‑126: Class 1 Device Recall CentriMag Acute Circulatory Support System Motor
Figure 4‑127: Class 2 Device Recall Arrow
Figure 4‑128: INSPIRIS RESILIA Aortic Valve, Valve-in-Valve Surveillance Study (INVIVITY)
Figure 4‑129: Avalus European Registry - an Observational Study to Evaluate Safety and Efficacy in a Real World Population
Figure 4‑130: PERCEVAL S Valve Clinical Study for Chinese Registration (PERFECT)
Figure 4‑131: INSPIRIS RESILIA Valve in Pulmonary Position
Figure 4‑132: Trifecta and Epic ViV Detailed Insights into Management Strategies and Outcomes
Figure 4‑133: Trifecta™ Long Term Follow-Up (LTFU) Study
Figure 4‑134: Post Market Clinical Follow-Up Study in Patients Treated with the On-X Ascending Aortic Prosthesis (AAP) (ASCEND)
Figure 4‑135: Regent China Post-Market Clinical Follow-up Study
Figure 4‑136: SJM Masters HP 15mm Rotatable Mechanical Heart Valve as Aortic Valve Replacement Therapy
Figure 4‑137: Retrospective Clinical Data Collection on Carbomedics OptiForm Mitral Heart Valve
Figure 4‑138: HALO: A Single Arm Prospective Investigation of the SJM™ Masters HP™ 15mm Rotatable Mechanical Heart Valve
Figure 4‑139: On-X Heart Valve - 17mm Aortic and 23mm Mitral
Figure 4‑140: HAART Annuloplasty Device Valve Repair Registry
Figure 4‑141: Annuloplasty Rings and Band Post-Market Clinical Follow-Up Study (ARB-PMCF)
Figure 4‑142: A Feasibility Study of the Millipede Transcatheter Annuloplasty Ring System in Patients with Functional Mitral Regurgitation
Figure 4‑143: Effectiveness and Durability Long-term Results of Tricuspid Annuloplasty with 3D Shaped Rings
Figure 4‑144: PRESERVE-MITRAL Post-Market Registry
Figure 4‑145: Transcatheter Mitral Valve InterventiOn Single Center Registry in CHinese Patients with Mitral Valve Disease
Figure 4‑146: Valveclip® Transcatheter Mitral Valve Repair Study
Figure 4‑147: Caisson Transcatheter Mitral Valve Replacement (TMVR) (INTERLUDE)
Figure 4‑148: Multicentre Study of MITRACLIP® Transcatheter Mitral Valve Repair in Patients with Severe Primary Mitral Regurgitation Eligible for High-risk Surgery (MITRA-HR)
Figure 4‑149: Mi-thos® Transcatheter Mitral Valve Replacement (First-in-Man Study)
Figure 4‑150: MitraClip for the Treatment of Moderate Functional Mitral Regurgitation: EVOLVE-MR (EVOLVE-MR)
Figure 4‑151: The MitraClip® EXPAND Study of the Next Generation of MitraClip® Devices
Figure 4‑152: Safety and Effectiveness of Edwards Lifesciences SAPIEN XT THV in the Chinese Population (China XT)
Figure 4‑153: The PROTEMBO Trial
Figure 4‑154: PROTECT TAVI - Prospective Randomized Outcome Study in TAVI Patients Undergoing Periprocedural Embolic Cerebral Protection with the Sentinel™ Device
Figure 4‑155: Transcatheter Aortic Valve Replacement (TAVR) Double Balloon Valvuloplasty
Figure 4‑156: Mini-invasive Balloon Aortic Valvuloplasty
Figure 4‑157: Comparison of Saphenous Vein Harvesting by Endoscopic Versus Open Conventional Methods
Figure 4‑158: CardioGenesis Transmyocardial Revascularization 1-Year Follow-Up Study
Figure 4‑159: LVAD Conditioning for Cardiac Recovery
Figure 4‑160: EXCOR Active Driving System for the EXCOR Pediatric VAD IDE Study
Figure 4‑161: Effect of Cardiac Resynchronization Therapy (CRT) on Left Ventricular Assist Device (LVAD) Function
Figure 4‑162: The Left Ventricular Assist Device (LVAD) Off or On Pump Implantation Study
Figure 4‑163: A Clinical Trial to Evaluate the HeartWare™ Ventricular Assist System
Figure 4‑164: Outcome of Patients Treated with IABP
Figure 4‑165: Intra-aortic Balloon Pump in Extensive Myocardial Infarction with Persistent Ischemia
Figure 4‑166: Carmat Total Artificial Heart as a Bridge to Transplant in Patients with Advanced Heart Failure
Figure 4‑167: SynCardia 70cc TAH-t for Destination Therapy
Figure 4‑168: Syncardia 50cc TAH-t as a Bridge to Transplant
Figure 4‑169: Tolerability and Safety of CARDIOMEMS™ Intracardiac Continuous Cardiac Hemodynamic Monitoring Device in Patients with Cardio Renal Syndrome with Severe Renal Impairment
Figure 4‑170: Investigation to Optimize Hemodynamic Management of Left Ventricular Assist Devices Using the CardioMEMS™
Figure 4‑171: AMPLATZER PFO Occluder Post Approval Study
Figure 4‑172: GORE® CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients with Patent Foramen Ovale (PFO): the REDUCE Post Approval Study
Figure 4‑173: GORE® CARDIOFORM Septal Occluder Migraine Clinical Study
Figure 4‑174: Evaluation of the Efficacy and Safety of a Simplified Procedure for the Percutaneous Closure of the Patent Foramen Ovale
Figure 4‑175: Amplatzer PFO Occluder Post-marketing Surveillance Study
Figure 4‑176: Internal Microstructure of Patent Foramen Ovale Related to Stroke
Figure 4‑177: Early Prediction of Spontaneous Patent Ductus Arteriosus (PDA) Closure and PDA-Associated Outcomes
Figure 4‑178: Amplatzer Piccolo Occluder Japan Post-Marketing Database Surveillance
Figure 4‑179: Nit-Occlud PDA Post-Approval Study
Figure 4‑180: Procedural Outcomes of Percutaneous PDA Closure: Comparative Study between Different Devices
Figure 4‑181: A Pilot Study to Assess WATCHMAN FLX™ Implants by Cardiac Computed Tomography, Magnetic Resonance Imaging and Transesophageal Echocardiography
Figure 4‑182: The ICE WATCHMAN Trial
Figure 4‑183: VClip Post-Market Study
Figure 4‑184: Observe the Safety and Effectiveness of the WATCHMAN FLX™ for Subjects in Hong Kong
Figure 4‑185: AtriClip® Left Atrial Appendage Exclusion Concomitant to Structural Heart Procedures
Figure 4‑186: CentriMag Failure-to-Wean Post Approval Study
Figure 4‑187: Quality of Life 1y and 2 y After VV-ECMO for COVID-19
Figure 4‑188: ECMO Treatment of Children in China in the Past 10 Years
Figure 4‑189: TandemHeart Experiences and MEthods
Figure 4‑190: Retrospective Data Analysis on the Application of Swan-Ganz Catheter in Cardiac Surgery
Figure 4‑191: Swan-Ganz Catheter Insertion
Figure 5‑1: Cardiac Market by Segment, U.S., 2019 – 2029 (US$M) (1 of 3)
Figure 5‑2: Cardiac Market by Segment, U.S., 2019 – 2029 (US$M) (2 of 3)
Figure 5‑3: Cardiac Market by Segment, U.S., 2019 – 2029 (US$M) (3 of 3)
Figure 5‑4: Leading Competitors, Cardiac Surgery Market, U.S., 2022 (1 of 4)
Figure 5‑5: Leading Competitors, Cardiac Surgery Market, U.S., 2022 (2 of 4)
Figure 5‑6: Leading Competitors, Cardiac Surgery Market, U.S., 2022 (3 of 4)
Figure 5‑7: Leading Competitors, Cardiac Surgery Market, U.S., 2022 (4 of 4)
Figure 5‑8: SWOT Analysis, Abbott (1 of 2)
Figure 5‑9: SWOT Analysis, Abbott (2 of 2)
Figure 5‑10: SWOT Analysis, Abiomed
Figure 5‑11: SWOT Analysis, Artivion
Figure 5‑12: SWOT Analysis, AtriCure
Figure 5‑13: SWOT Analysis, B. Braun
Figure 5‑14: SWOT Analysis, Boston Scientific
Figure 5‑15: SWOT Analysis, Edwards Lifesciences
Figure 5‑16: SWOT Analysis, Getinge
Figure 5‑17: SWOT Analysis, LivaNova
Figure 5‑18: SWOT Analysis, Medtronic
Figure 5‑19: SWOT Analysis, Terumo
Figure 6‑1: Procedure Codes Investigated, U.S., 2022
Figure 6‑2: Cardiac Surgery and Heart Valve Procedures by Segment, U.S., 2019 – 2029 (1 of 3)
Figure 6‑3: Cardiac Surgery and Heart Valve Procedures by Segment, U.S., 2019 – 2029 (2 of 3)
Figure 6‑4: Cardiac Surgery and Heart Valve Procedures by Segment, U.S., 2019 – 2029 (3 of 3)
Figure 6‑5: Surgical Heart Valve Procedures by Segment, U.S., 2019 – 2029
Figure 6‑6: Tissue Heart Valve Procedures by Valve Type, U.S., 2019 – 2029
Figure 6‑7: 6.3.2 Tissue Heart Valve Procedures by Tissue Type, U.S., 2019 – 2029
Figure 6‑8: 6.3.3 Tissue Heart Valve Procedures by Device Type, U.S., 2019 – 2029
Figure 6‑9: 6.3.4 Mechanical Heart Valve Procedures by Valve Type, U.S., 2019 – 2029
Figure 6‑10: Mechanical Heart Valve Procedures by Segment, U.S., 2019 – 2029
Figure 6‑11: Annuloplasty Repair Procedures by Valve Type, U.S., 2019 – 2029
Figure 6‑12: Annuloplasty Repair Procedures by Device Type, U.S., 2019 – 2029
Figure 6‑13: Transcatheter Mitral Valve Repair (TMVr) Procedures by Approach, U.S., 2019 – 2029
Figure 6‑14: Transcatheter Mitral Valve Repair (TMVr) Procedures by Disease Type, U.S., 2019 – 2029
Figure 6‑15: Transcatheter Heart Valve Replacement Procedures by Valve Type, U.S., 2019 – 2029
Figure 6‑16: TAVR Procedures by Approach, U.S., 2019 – 2029
Figure 6‑17: TAVR Procedures by Patient Risk Class, U.S., 2019 – 2029
Figure 6‑18: TAVR Procedures by Embolic Protection, U.S., 2019 – 2029
Figure 6‑19: TAVR Procedures by Location, U.S., 2019 – 2029
Figure 6‑20: TAVR Procedures by Valve Type, U.S., 2019 – 2029
Figure 6‑21: TPVR Procedures, U.S., 2019 – 2029
Figure 6‑22: Balloon Valvuloplasty Procedures by Segment, U.S., 2019 – 2029
Figure 6‑23: CABG Procedures by Bypass Type, U.S., 2019 – 2029
Figure 6‑24: CABG Vessel Harvesting Procedures by Type, U.S., 2019 – 2029
Figure 6‑25: CABG Procedures by Suture Type, U.S., 2019 – 2029
Figure 6‑26: CABG Procedures by Approach, U.S., 2019 – 2029
Figure 6‑27: Transmyocardial Revascularization Procedures, U.S., 2019 – 2029
Figure 6‑28: Ventricular Assist Device Procedures by Segment, U.S., 2019 – 2029
Figure 6‑29: Percutaneous VAD Procedures by Heart Side, U.S., 2019 – 2029
Figure 6‑30: Percutaneous VAD Procedures by Indication, U.S., 2019 – 2029
Figure 6‑31: Implantable VAD Procedures by Indication, U.S., 2019 – 2029
Figure 6‑32: Implantable VAD Procedures by Type, U.S., 2019 – 2029
Figure 6‑33: External VAD Procedures by Type, U.S., 2019 – 2029
Figure 6‑34: IABP Procedures by Setting, U.S., 2019 – 2029
Figure 6‑35: IABP Procedures by Device Type, U.S., 2019 – 2029
Figure 6‑36: Heart Transplant Procedures by Type, U.S., 2019 – 2029
Figure 6‑37: Remote Hemodynamic Monitoring System Procedures, U.S., 2019 – 2029
Figure 6‑38: Patent Foramen Ovale Closure Procedures by Type, U.S., 2019 – 2029
Figure 6‑39: Patent Ductus Arteriosus Device Procedures, U.S., 2019 – 2029
Figure 6‑40: Septal Defect Closure Procedures by Type, U.S., 2019 – 2029
Figure 6‑41: ASD Closure Procedures by Type, U.S., 2019 – 2029
Figure 6‑42: VSD Closure Procedures by Type, U.S., 2019 – 2029
Figure 6‑43: LAA Procedures by Type, U.S., 2019 – 2029
Figure 6‑44: Epicardial Device Closure Procedures by Type, U.S., 2019 – 2029
Figure 6‑45: Epicardial Clip Procedures by Type, U.S., 2019 – 2029
Figure 6‑46: Extracorporeal Membrane Oxygenation Procedures by Modality, U.S., 2019 – 2029
Figure 6‑47: Extracorporeal Membrane Oxygenation Procedures by Application, U.S., 2019 – 2029
Figure 6‑48: Respiratory Extracorporeal Membrane Oxygenation Procedures by Age Group, U.S., 2019 – 2029
Figure 6‑49: Cardiac Extracorporeal Membrane Oxygenation Procedures by Age Group, U.S.,  2019 – 2029
Figure 6‑50: eCPR ECMO Procedures by Age Group, U.S., 2019 – 2029
Figure 7‑1: Tissue Heart Valve Market by Segment, U.S., 2019 – 2029 (US$M)
Figure 7‑2: Total Tissue Heart Valve Market, U.S., 2019 – 2029
Figure 7‑3: Stented Market, U.S., 2019 – 2029
Figure 7‑4: Stentless Market, U.S., 2019 – 2029
Figure 7‑5: Sutureless/Rapid Deployment Market, U.S., 2019 – 2029
Figure 7‑6: Tissue Heart Valve Market by Tissue Type, U.S., 2019 – 2029 (US$M)
Figure 7‑7: Leading Competitors, Tissue Heart Valve Market, U.S., 2022
Figure 8‑1: Total Mechanical Heart Valve Market by Segment, U.S., 2019 – 2029 (US$M)
Figure 8‑2: Total Mechanical Heart Valve Market, U.S., 2019 – 2029
Figure 8‑3: Without Conduit Market, U.S., 2019 – 2029 (US$M)
Figure 8‑4: With Conduit Market, U.S., 2019 – 2029
Figure 8‑5: Leading Competitors, Mechanical Heart Valve Market, U.S., 2022
Figure 9‑1: Annuloplasty Repair Device Market by Segment, U.S., 2019 – 2029 (US$M)
Figure 9‑2: Total Annuloplasty Repair Device Market, U.S., 2019 – 2029
Figure 9‑3: Ring Market, U.S., 2019 – 2029 (US$M)
Figure 9‑4: Band Market, U.S., 2019 – 2029
Figure 9‑5: Leading Competitors, Annuloplasty Repair Device Market, U.S., 2022
Figure 10‑1: Transcatheter Mitral Valve Repair Market, U.S., 2019 – 2029
Figure 10‑2: Leading Competitors, Transcatheter Mitral Valve Repair Market, U.S., 2022
Figure 11‑1: Transcatheter Heart Valve Replacement Market by Segment, U.S., 2019 – 2029 (US$M)
Figure 11‑2: Total Transcatheter Heart Valve Replacement Market, U.S., 2019 – 2029
Figure 11‑3: Transcatheter Aortic Valve Replacement Market, U.S., 2019 – 2029
Figure 11‑4: Transcatheter Pulmonary Valve Replacement Market, U.S., 2019 – 2029
Figure 11‑5: Leading Competitors, Transcatheter Heart Valve Replacement Market, U.S., 2022
Figure 12‑1: Temporary Pacing and Pressure Measurement Catheter Market, U.S., 2019 – 2029
Figure 12‑2: Leading Competitors, Temporary Pacing and Pressure Measurement Catheter Market, U.S., 2022
Figure 13‑1: Cerebral Embolic Protection Device Market, U.S., 2019 – 2029
Figure 13‑2: Leading Competitors, Cerebral Embolic Protection Device Market, U.S., 2022
Figure 14‑1: Total Balloon Valvuloplasty Market by Segment, U.S., 2019 – 2029 (US$M)
Figure 14‑2: Total Balloon Valvuloplasty Market, U.S., 2019 – 2029
Figure 14‑3: Aortic Market, U.S., 2019 – 2029
Figure 14‑4: Mitral Market, U.S., 2019 – 2029
Figure 14‑5: Pulmonary Market, U.S., 2019 – 2029
Figure 14‑6: Hybrid Market, U.S., 2019 – 2029
Figure 14‑7: Leading Competitors, Balloon Valvuloplasty Market, U.S., 2022
Figure 15‑1: ONCAB Device Market by Segment, U.S., 2019 – 2029 (US$M)
Figure 15‑2: On-Pump Coronary Artery Bypass Disposables Market by Segment, U.S., 2019 – 2029 (US$M) (1 of 2)
Figure 15‑3: ONCAB Disposables Market by Segment, U.S., 2019 – 2029 (US$M) (2 of 2)
Figure 15‑4: Total ONCAB Disposables Market, U.S., 2019 – 2029
Figure 15‑5: Oxygenator Market, U.S., 2019 – 2029
Figure 15‑6: Reservoir Market, U.S., 2019 – 2029
Figure 15‑7: Cardioplegia Set Market, U.S., 2019 – 2029
Figure 15‑8: Filter Market, U.S., 2019 – 2029
Figure 15‑9: Pump Head Market, U.S., 2019 – 2029
Figure 15‑10: Bubble Trap Market, U.S., 2019 – 2029
Figure 15‑11: Hemoconcentrator Market, U.S., 2019 – 2029
Figure 15‑12: Custom Tubing Kit Market, U.S., 2019 – 2029
Figure 15‑13: Other Market, U.S., 2019 – 2029
Figure 15‑14: Perfusion System Market, U.S., 2019 – 2029
Figure 15‑15: Leading Competitors, On-Pump Coronary Artery Bypass Device Market, U.S., 2022
Figure 16‑1: Off-Pump Coronary Artery Bypass Device Market by Segment, U.S.,  2019 – 2029 (US$M)
Figure 16‑2: Total Off-Pump Coronary Artery Bypass Device Market, U.S., 2019 – 2029
Figure 16‑3: Stabilizer Device Market, U.S., 2019 – 2029
Figure 16‑4: Positioner Market, U.S., 2019 – 2029
Figure 16‑5: Accessory Market by Segment, U.S., 2019 – 2029 (US$M)
Figure 16‑6: Total Accessory Market, U.S., 2019 – 2029
Figure 16‑7: Blower/Mister Market, U.S., 2019 – 2029
Figure 16‑8: Intracoronary Shunt Market, U.S., 2019 – 2029
Figure 16‑9: Leading Competitors, Off-Pump Coronary Artery Bypass Device Market, U.S., 2022
Figure 17‑1: Autotransfusion Device Market by Segment, U.S., 2019 – 2029 (US$M)
Figure 17‑2: Autotransfusion Machine Market, U.S., 2019 – 2029
Figure 17‑3: Autotransfusion Machine Installed Base Market, U.S., 2019 – 2029
Figure 17‑4: Autotransfusion Disposables Market, U.S., 2019 – 2029
Figure 17‑5: Leading Competitors, Autotransfusion Device Market, U.S., 2022
Figure 18‑1: Endoscopic Vessel Harvesting Device Market, U.S., 2019 – 2029
Figure 18‑2: Leading Competitors, Endoscopic Vessel Harvesting Device Market, U.S., 2022
Figure 19‑1: Total Anastomosis Assist Device Market by Segment, U.S., 2019 – 2029 (US$M)
Figure 19‑2: Total Anastomosis Assist Device Market, U.S., 2019 – 2029
Figure 19‑3: Proximal Anastomosis Assist Device Market, U.S., 2019 – 2029
Figure 19‑4: Distal Anastomosis Assist Device Market, U.S., 2019 – 2029
Figure 19‑5: Leading Competitors, Anastomosis Assist Device Market, U.S., 2022
Figure 20‑1: Transmyocardial Revascularization Market by Segment, U.S., 2019 – 2029 (US$M)
Figure 20‑2: Single-Use Fiber-Optic Handpiece Market, U.S., 2019 – 2029
Figure 20‑3: Transmyocardial Revascularization Laser Console Market by Segment, U.S.,  2019 – 2029 (US$M)
Figure 20‑4: Leading Competitors, Transmyocardial Revascularization Market, U.S., 2022
Figure 21‑1: Ventricular Assist Device Market by Segment, U.S., 2019 – 2029 (US$M)
Figure 21‑2: Total Ventricular Assist Device Market, U.S., 2019 – 2029
Figure 21‑3: Percutaneous VAD Market by Segment, U.S., 2019 – 2029 (US$M)
Figure 21‑4: Total Percutaneous VAD Market, U.S., 2019 – 2029
Figure 21‑5: Left Heart Percutaneous VAD Market, U.S., 2019 – 2029
Figure 21‑6: Right Heart Percutaneous VAD Market, U.S., 2019 – 2029
Figure 21‑7: External VAD Market by Segment, U.S., 2019 – 2029 (US$M)
Figure 21‑8: Total External VAD Market, U.S., 2019 – 2029
Figure 21‑9: Short-Term External VAD Market, U.S., 2019 – 2029
Figure 21‑10: Long-Term External VAD Market, U.S., 2019 – 2029
Figure 21‑11: Implantable VAD Market, U.S., 2019 – 2029 (US$M)
Figure 21‑12: Implantable VAD Market Unit Analysis, U.S., 2019 – 2029
Figure 21‑13: Leading Competitors, Ventricular Assist Device Market, U.S., 2022
Figure 22‑1: Intra-Aortic Balloon Pump Market by Segment, U.S., 2019 – 2029 (US$M)
Figure 22‑2: Total Intra-Aortic Balloon Pump Market, U.S., 2019 – 2029
Figure 22‑3: Intra-Aortic Balloon Pump Catheter Market by Segment, U.S., 2019 – 2029 (US$M)
Figure 22‑4: Total Intra-Aortic Balloon Pump Catheter Market, U.S., 2019 – 2029
Figure 22‑5: Conventional Intra-Aortic Balloon Pump Catheter Market, U.S., 2019 – 2029
Figure 22‑6: Fiber-Optic Intra-Aortic Balloon Pump Catheter Market, U.S., 2019 – 2029
Figure 22‑7: Intra-Aortic Balloon Pump Console Market, U.S., 2019 – 2029
Figure 22‑8: Leading Competitors, Intra-Aortic Balloon Pump Market, U.S., 2022
Figure 23‑1: Artificial Heart Replacement Device Market, U.S., 2019 – 2029
Figure 23‑2: Leading Competitors, Artificial Heart Replacement Device Market, U.S., 2022
Figure 24‑1: Remote Hemodynamic Monitoring System Market, U.S., 2019 – 2029
Figure 24‑2: Leading Competitors, Remote Hemodynamic Monitoring System Market, U.S., 2022
Figure 25‑1: Patent Foramen Ovale Closure Device Market, U.S., 2019 – 2029
Figure 25‑2: Leading Competitors, Patent Foramen Ovale Closure Device Market, U.S., 2022
Figure 26‑1: Patent Ductus Arteriosus Closure Device Market, U.S., 2019 – 2029
Figure 26‑2: Leading Competitors, Patent Ductus Arteriosus Closure Device Market, U.S., 2022
Figure 27‑1: Atrial Septal & Ventricular Septal Defect Closure Device Market by Segment, U.S., 2019 – 2029 (US$M)
Figure 27‑2: Total Atrial Septal & Ventricular Septal Defect Closure Device Market, U.S.,  2019 – 2029
Figure 27‑3: Atrial Septal Defect Closure Device Market, U.S., 2019 – 2029
Figure 27‑4: Ventricular Septal Defect Closure Device Market, U.S., 2019 – 2029
Figure 27‑5: Leading Competitors, Atrial Septal & Ventricular Septal Defect Closure Device Market, U.S., 2022
Figure 28‑1: Left Atrial Appendage Closure Device Market by Segment, U.S., 2019 – 2029 (US$M)
Figure 28‑2: Total Left Atrial Appendage Closure Device Market, U.S., 2019 – 2029
Figure 28‑3: Epicardial Device Market by Segment, U.S., 2019 – 2029 (US$M)
Figure 28‑4: Total Epicardial Device Market, U.S., 2019 – 2029
Figure 28‑5: Epicardial Clip Device Market by Segment, U.S., 2019 – 2029 (US$M)
Figure 28‑6: Open Epicardial Clip Device Market, U.S., 2019 – 2029
Figure 28‑7: MIS Epicardial Clip Device Market, U.S., 2019 – 2029
Figure 28‑8: Epicardial Suture Device Market, U.S., 2019 – 2029
Figure 28‑9: Endocardial Device Market, U.S., 2019 – 2029
Figure 28‑10: Leading Competitors, Left Atrial Appendage Closure Device Market, U.S., 2022
Figure 29‑1: Preshaped Guidewire Market, U.S., 2019 – 2029
Figure 29‑2: Leading Competitors, Preshaped Guidewire Market, U.S., 2022
Figure 30‑1: Extracorporeal Membrane Oxygenation Market by Segment, U.S., 2019 – 2029 (US$M)
Figure 30‑2: Extracorporeal Membrane Oxygenation Machine Market, U.S., 2019 – 2029
Figure 30‑3: Extracorporeal Membrane Oxygenation Disposables Market by Segment, U.S.,  2019 – 2029 (US$M)
Figure 30‑4: Total Extracorporeal Membrane Oxygenation Disposables Market, U.S., 2019 – 2029
Figure 30‑5: Venovenous Market, U.S., 2019 – 2029
Figure 30‑6: Venoarterial Market, U.S., 2019 – 2029
Figure 30‑7: Arteriovenous Market, U.S., 2019 – 2029
Figure 30‑8: Leading Competitors, Extracorporeal Membrane Oxygenation Market, U.S., 2022

iData’s 9-Step Research Methodology

Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology

Explore Options

Report Summary

FREE

Select License Type

  • 2023
  • 10 Years
  • United States
  • 08/30/2023
  • 543
  • MedSuite
0
    0
    Your Cart
    Your cart is emptyReturn to Report Library